Handel nachbörslich: 1.41 0.01 +0.71%

Calidi Biotherapeutics Inc (CLDI)

Überblick Nachrichten Preisverlauf Forum Prognose

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle

Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World

CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Calidi to present data supporting RTNova at upcoming conferences - TipRanks

SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times

Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance

Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN

CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa

CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com

Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga

Calidi Biotherapeutics secures $2 million in equity financing - Investing.com

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times

Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - ForexTV.com

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail

Cocoa #7 (CAU21) Quote - The Globe and Mail

Wendy Pizarro - Los Angeles Times

CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada

Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail

Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian

Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com

Calidi Biotherapeutics Presents Antitumor Virotherapy Advances - TipRanks

Calidi Biotherapeutics stock target cut by Baird with Outperform tag maintained - Investing.com

Calidi price target lowered to $2.50 from $20 at Baird - TipRanks

CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024 - MSN

Calidi Biotherapeutics Inc (CLDI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

CLDI Stock Plummets to 52-Week Low at $1.41 Amid Market Turbulence - Investing.com

Calidi Biotherapeutics Unveils Redtail Biopharma Subsidiary - TipRanks

Calidi Biotherapeutics announces board reduction following director's exit By Investing.com - Investing.com South Africa

Calidi Biotherapeutics announces board reduction following director's exit - Investing.com

Calidi Biotherapeutics Board Reshuffles as Advisor Departs - TipRanks

Calidi Biotherapeutics (NYSE:CLDI) Releases Earnings Results - Defense World

Calidi Biotherapeutics (NYSE:CLDI) Issues Quarterly Earnings Results - MarketBeat

Why Calidi Biotherapeutics is Moving Higher Monday - MSN

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results - BioSpace

Biotech Spins Off Subsidiary for Stem Cell Therapy - San Diego Business Journal

UMACUnusual Machines, Inc. Latest Stock News & Market Updates - StockTitan

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Metric Analysis: Calidi Biotherapeutics Inc (CLDI)’s Key Ratios in the Limelight - The Dwinnex

CLDI’s price-to-cash ratio: How it affects the stock’s valuation. - US Post News

Calidi Biotherapeutics Secures Investment, Expands Advisory Board - TipRanks

Ähnlich wie CLDI